A New T-Cell activation assay based on Hyris qPCR Technology

A scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris

Related Keywords

Italy , London , City Of , United Kingdom , Singapore , Cristina Lapucci , Kostenloser Wertpapierhandel , Jordi Ochando , Ernesto Guccione , Antonio Bertoletti , Megan Schwarz , Professor Of Oncological Sciences , Icahn School Of Medicine At Mount Sinai , Icahn School Mount Sinai , Pharmacological Sciences , Nature Biotechnology , Icahn School , Mount Sinai , Molecular Biology , Stefano Lo Priore , Oncological Sciences , Icahn Mount , Assistant Professor , Cell Based Medicine , Cell , Activation , Essay , Ased , Tyris , Pcr , Technology , Parks , Disruptive , Approach , Detection , Cars , Specific , Ellular , Immunity ,